Europium-doped amorphous calcium phosphate porous nanospheres: Preparation and application as luminescent drug carriers

Nanoscale Research Letters

Volumn 6, Issue 1, 2011, Pages

  Chen, Feng ^a   Zhu, Ying Jie ^a   Zhang, Kui Hua ^b   Wu, Jin ^a   Wang, Ke Wei ^a   Tang, Qi Li ^a   Mo, Xiu Mei ^b  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b DONGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BODY FLUIDS; CALCIUM PHOSPHATE; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; EUROPIUM COMPOUNDS; HYDROXYAPATITE; NANOSPHERES; CALCIUM; EUROPIUM; EXPERIMENTS; TISSUE;

AMORPHOUS CALCIUM PHOSPHATE; BIOLOGICAL TISSUES; HIGH SPECIFIC SURFACE AREA; HYBRID NANOPARTICLE; LINEAR RELATIONSHIPS; NATURAL LOGARITHMS; SIMULATED BODY FLUIDS; SUSTAINED DRUG RELEASE; CUMULATIVE AMOUNT; DRUG CARRIER; DRUG RELEASE; EUROPIUM-DOPED; FACILE METHOD; IN-VITRO; NANOCARRIERS; PL PROPERTY; RELEASE TIME;

TARGETED DRUG DELIVERY; CALCIUM PHOSPHATE;

EID: 84255173439     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-6-67     Document Type: Article

References (51)

1. Shi D: Integrated multifunctional nanosystems for medical diagnosis and treatment. Adv Funct Mater 2009, 19:3356.
2. Park K, Lee S, Kang E, Kim K, Choi K, Kwon IC: New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv Funct Mater 2009, 19:1553.
3. Sanvicens N, Marco MP: Multifunctional nanoparticles-properties and prospects for their use in human medicine. Trends Biotechnol 2008, 26:425.
4. Gunasekera MP, Pankhurst QA, Douek M: Imaging applications of nanotechnology in cancer. Target Oncol 2009, 4:169.
5. Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie S, O'Regan RM: Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol 2006, 7:657.
6. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP: Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281:2013.
7. Seydel C: Quantum dots get wet. Science 2003, 300:80.
8. Gao X, Cui Y, Levenson RM, Chung LW, Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969.
9. Choi J, Burns AA, Williams RM, Zhou Z, Flesken-Nikitin A, Zipfel WR, Wiesner U, Nikitin AY: Core-shell silica nanoparticles as fluorescent labels for nanomedicine. J Biomed Opt 2007, 12:064007.
10. Kim D, Park S, Lee JH, Jeong YY, Jon S: Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 2007, 129:7661
11. Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X, Dai H: In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007, 2:47.
12. Tomalia DA, Reyna LA, Svenson S: Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 2007, 35:61.
13. Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA: Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst 2004, 96:703.
14. Shi X, Wang S, Meshinchi S, Van Antwerp ME, Bi X, Lee I, Baker JR Jr: Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 2007, 3:1245.
15. Yu MK, Jeong YY, Park J, Park S, Kim JW, Min JJ, Kim K, Jon S: Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed 2008, 47:5362.
16. Landmark KJ, Dimaggio S, Ward J, Kelly C, Vogt S, Hong S, Kotlyar A, Myc A, Thomas TP, Penner-Hahn JE, Baker JR, Holl MM, Orr BG: Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers. ACS Nano 2008, 2:773.
17. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M: Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007, 2:23.
18. Lee H, Yu MK, Park S, Moon S, Min JJ, Jeong YY, Kang HW, Jon S: Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J Am Chem Soc 2007, 129:12739.
19. Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y, Lee KH: Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol 2007, 19(Suppl 1):59.
20. Tian F, Cui D, Schwarz H, Estrada GG, Kobayashi H: Cytotoxicity of singlewall carbon nanotubes on human fibroblasts. Toxicol In Vitro 2006, 20:1202.
21. Papageorgiou I, Brown C, Schins R, Singh S, Newson R, Davis S, Fisher J, Ingham E, Case CP: The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials 2007, 28:2946.
22. Driessens FCM, van Dijk JWE, Borggreven JMPM: Biological calcium phosphates and their role in the physiology of bone and dental tissues I. Composition and solubility of calcium phosphates. Calcif Tissue Int 1978, 26:127.
23. Vallet-Regí M, González-Calbet JM: Calcium phosphates as substitution of bone tissues. Prog Solid State Chem 2004, 32:1.
24. Weiner S, Addadi S: Design strategies in mineralized biological materials. J Mater Chem 1997, 7:689.
25. Cai YR, Tang RK: Calcium phosphate nanoparticles in biomineralization and biomaterials. J Mater Chem 2008, 18:3775.
26. Stupp SI, Braun PV: Molecular manipulation of microstructures: biomaterials, ceramics, and semiconductors. Science 1997, 277:1242.
27. Suchanek W, Yoshimura M: Processing and properties of hydroxyapatitebased biomaterials for use as hard tissue replacement implants. J Mater Res 1998, 13:94.
28. Ma MY, Zhu YJ, Li L, Cao SW: Nanostructured porous hollow ellipsoidal capsules of hydroxyapatite and calcium silicate: preparation and application in drug delivery. J Mater Chem 2008, 18:2722.
29. Tang QL, Zhu YJ, Duan YR, Wang Q, Wang KW, Cao SW, Chen F, Wu J: Porous nanocomposites of PEG-PLA/calcium phosphate: roomtemperature synthesis and its application in drug delivery. Dalton Trans 2010, 39:4435.
30. Maitra A: Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy. Expert Rev Mol Diagn 2005, 5:893.
31. Wang KW, Zhou LZ, Sun Y, Wu GJ, Gu HC, Duan YR, Chen F, Zhu YJ: Calcium phosphate/PLGA-mPEG hybrid porous nanospheres: A promising vector with ultrahigh gene loading and transfection efficiency. J Mater Chem 2010, 20:1161.
32. Al-Kattan A, Dufour P, Dexpert-Ghys J, Drouet C: Preparation and physicochemical characteristics of luminescent apatite-based colloids. J Phys Chem C 2010, 114:2918.
33. Doat A, Fanjul M, Pelle F, Hollande E, Lebugle A: Europium-doped bioapatite: a new photostable biological probe, internalizable by human cells. Biomaterials 2003, 24:3365.
34. Doat A, Pelle F, Gardant N, Lebugle A: Synthesis of luminescent bioapatite nanoparticles for utilization as a biological probe. J Solid State Chem 2004, 177:1179.
35. Han YC, Wang XY, Li SP: Biocompatible europium doped hydroxyapatite nanoparticles as a biological fluorescent probe. Curr Nanosci 2010, 6:178.
36. Kim EJ, Choi SW, Hong SH: Synthesis and photoluminescence properties of Eu3+-doped calcium phosphates. J Am Ceram Soc 2007, 90:2795.
37. Lebugle A, Pelle F, Charvillat C, Rousselot I, Chane-Ching JY: Colloidal and monocrystalline Ln3+ doped apatite calcium phosphate as biocompatible fluorescent probes. Chem Commun 2006, 606.
38. Yang PP, Quan ZW, Li CX, Kang XJ, Lian HZ, Lin J: Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier. Biomaterials 2008, 29:4341.
39. Nagano M, Nakamura T, Kokubo T, Tanahashi M, Ogawa M: Differences of bone bonding ability and degradation behaviour in vivo between amorphous calcium phosphate and highly crystalline hydroxyapatite coating. Biomaterials 1996, 17:1771.
40. Balasundaram G, Sato M, Webster TJ: Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials 2006, 27:2798.
41. Dorozhkin SV: Calcium Orthophosphates in Nature, Biology and Medicine. Materials 2009, 2:399.
42. Ramchandani M, Pankaskie M, Robinson D: The influence of manufacturing procedure on the degradation of poly(lactide-coglycolide) 85:15 and 50:50 implants. J Control Release 1997, 43:161.
43. Jain A: The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21:2475.
44. Xu GF, Aksay IA, Groves JT: Continuous crystalline carbonate apatite thin films. A biomimetic approach. J Am Chem Soc 2001, 123:2196.
45. Horikoshi K, Hata K, Kawabata N, Ikawa SI, Konaka S: Vibrational spectra and conformation of polyethylene glycol complexed with calcium and magnesium chlorides. J Mol Struct 1990, 239:33.
46. Uekawa N, Sukegawa T, Kakegawa K, Sasaki Y: Synthesis of Lead Nickel Niobate-Barium Titanate System by Oxidation of Polyethylene Glycol- Cation Complex. J Am Ceram Soc 2002, 85:329.
47. Sing KSW, Everett DH, Haul RAW, Moscou L, Pierotti RA, Rouquerol J, Siemieniewska T: Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984). Pure Appl Chem 1985, 57:603.
48. Wu J, Zhu YJ, Cao SW, Chen F: Hierachically nanostructured mesoporous spheres of calcium silicate hydrate: surfactant-free sonochemical synthesis and drug-delivery system with ultrahigh drug-loading capacity. Adv Mater 2010, 22:749.
49. Higuchi T: Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963, 52:1145.
50. Vallet-Regi M, Balas F, Arcos D: Mesoporous materials for drug delivery. Angew Chem Int Ed 2007, 46:7548.
51. Andersson J, Rosenholm J, Areva S, Lindén M: Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mater 2004, 16:4160.